Sales Growth YoY (Last Twelve Months): Carmell Therapeutics (CTCX)

Graphic logo of Carmell Therapeutics (CTCX)

Year-over-year (LTM) gross revenue dynamics confirm the resilience of Carmell Corporation (CTCX) as a defensive asset independent of global macroeconomic shocks. Carmell Corporation (CTCX) relies on a regenerative biomedical ecosystem that creates high switching costs for customers. Plasma biomaterials for tissue healing ensure a steady stream of orders from hospitals, while the value of serves as the current figure for this metric.

Sales Growth YoY (Last Twelve Months): Carmell Corp (CTCX) for 07/04/2022 - 11/19/2026

Carmell Corp. (CTCX) - metric breakdowns and financial figures

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Summary company analytics:CTCX (Carmell Therapeutics)
Mass-produced product of Carmell

For an investor in Carmell Corporation (CTCX), this indicator serves as a benchmark for the expansion efficiency of bioactive materials within the regenerative medicine and aesthetics markets. By analyzing the rolling 12-month sales growth versus the same period last year, which calculates the percentage change in revenue over the last four quarters, one can assess the actual pace of market share capture and the fundamental stability of the business's commercial scaling.

Competitors of Carmell Corporation (CTCX)

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) newamsterdampharma.com NAMS|Sales Growth YoY (Last Twelve Months) Soleno Therapeutics Inc SLNO|Sales Growth YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) MiMedx Group, Inc.|Sales Growth YoY (Last Twelve Months) Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) MBX|Revenue Growth YoY (Last 12 Months) Altimmune, Inc. ALT|Sales Growth YoY (TTM) AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Trailing Twelve Months Revenue Growth|BIOA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) BMEA (Biomea Fusion)|QNCX (quincetx.com) - Revenue Growth YoY (Last 12 Months)|Fractyl - Revenue Dynamics YoY (Last Twelve Months)|VTVT (vTv Therapeutics Inc) - Sales Growth YoY (TTM)|Agape ATP - Trailing Twelve Months Sales Growth|Revenue Growth YoY (Last 12 Months) PLUR (Pluri Inc)|Annual Revenue Growth (Last Twelve Months) Synlogic Inc.|Sales Growth YoY (Last Twelve Months) Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Trailing Twelve Months Revenue Growth|Spruce Biosciences Inc. - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) Galecto, Inc. GLTO|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)